Recovery study after Cushing surgery for cortisol excess
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how people recover after surgery to treat Cushing syndrome and mild cortisol overproduction. It may help doctors understand what recovery looks like and how treatment affects cortisol levels and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have a new diagnosis of Cushing syndrome or mild autonomous cortisol secretion (MACS)
- Your Cushing/MACS is from the pituitary, adrenal, or ectopic source
- You are planning a surgery meant to cure the condition
- You can understand the study and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Cushing’s syndrome affects people before treatment and what changes after treatment. It may help researchers understand what to expect and improve care for adults with newly diagnosed Cushing’s syndrome.
This is a study that collects and reviews information about how people with Cushing’s syndrome (including some mild forms and certain “silent” tumors) are diagnosed and treated, and what outcomes they have. It may help researchers understand which treatments work best in different types of the condition.
This study follows adults with a new adrenal diagnosis to learn how adrenal diseases behave over time. It may help doctors better understand these conditions and improve future care.
This trial tests a new way to use a medicine called desmopressin with a special type of imaging (PET/CT) to help find cortisol-producing tumors in people with Cushing's syndrome. It may help doctors better locate the problem without needing as much radiation.
This study tests if a medication called metyrapone can help people with mild autonomous cortisol secretion (MACS), a condition where your body makes too much cortisol. It looks at whether the drug improves related health problems like high blood pressure, diabetes, or bone issues.
This study tests whether a low dose of the drug osilodrostat can help people with mild cortisol excess (MACS) caused by benign adrenal tumors. It may improve related health problems like high blood pressure, diabetes, or bone thinning.
Hear when a new Cushing Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.